Guided breathing to improve stress and heart rate variability in autistic young adults
Official title: Promoting Emotional and Autonomic Control Through Guided Breathing Exercises for Emerging Adults With Autism
Run by Universitaire Ziekenhuizen KU Leuven · NCT07238153 · Data updated 2026-11-12
This study will test two guided breathing exercises to see if they reduce stress and improve heart rate variability in autistic people aged 16–25.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 16 Years to 25 Years |
| Sex | All |
| Enrollment | 68 (estimated) |
| Sponsor | Universitaire Ziekenhuizen KU Leuven Academic / other |
| Locations | 2 sites (Leuven, Vlaams Brabant and 1 other locations) |
| Status | Recruiting |
| Started | November 30, 2025 |
| Main results expected | April 1, 2028 |
| Study ends | April 1, 2028 |
| Registry record updated | April 29, 2026 |
| Trial ID | NCT07238153 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Autistic individuals aged 16–25 who can provide consent (or whose guardians can consent), and who do not have intellectual disability or serious uncontrolled cardiac, respiratory, or psychiatric conditions, are the intended participants.
✕Probably not a fit
People with congenital heart disease, severe respiratory illness, uncontrolled epilepsy, active severe psychiatric symptoms, intellectual disability, or those outside the 16–25 age range are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants aged 16–25 with an autism diagnosis will practice two types of guided breathing (slow-paced breathing and HRV biofeedback) while researchers record heart rate variability and stress-related measures. Daily movement behaviour—sleep, physical activity, and sedentary time—will be tracked to understand how these behaviours influence HRV. The study pairs physiological monitoring with questionnaires about the usability and perceived usefulness of the exercises. People with significant cardiovascular, respiratory, intellectual, or severe psychiatric conditions are excluded and sessions take place at KU Leuven/UPC Z.Org in Leuven, Belgium.
Why it matters
Potential benefit: If effective, these breathing exercises could offer an accessible, low-cost way for autistic young adults to manage stress and improve autonomic regulation.
How similar studies have gone: Breathing techniques and HRV biofeedback have shown benefits for stress and autonomic regulation in other populations, but strong evidence specifically in autistic young adults is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * For participants ≥18 years a voluntary written informed consent and for participants \< 18 years a written informed consent from the parents or their legally authorized representative and an informed assent of the participant has been obtained prior to any screening procedures * Male or Female (biological) * Between 16 and 25 years old * Diagnosis of autism as described in the DSM-IV/DSM-5(-TR) Exclusion Criteria: * Participant has a history of congenital heart diseases, diagnosed cardiovascular abnormalities or somatic diseases conditions that may interfere with the main outcome measure HRV or with the safe practice of breathing exercises (e.g., uncontrolled epilepsy, severe respiratory illness) * Presence of contra-indications for participating (intervention and/or assessment): acute agitation and/or severe psychiatric symptoms (psychosis, mania or major depression) and/or active substance use. * The presence of an intellectual disability, defined as an intelligence quotient \< 70, as described in the DSM-IV/DSM-V. * Insufficient knowledge of Dutch language in order to follow instructions and fill out questionnaires. * Female who is pregnant. * Participation in another interventional study, with or without an investigational medicinal product (IMP) or device (IMD). * The use of medication known to affect cardiac modulation (excluding hormonal contraceptives). * Hearing- or vision impairment that cannot be corrected to normal functioning.
Where it's running
-
KU Leuven
Leuven, Vlaams Brabant, Belgium Recruiting -
UPC Z.Org
Leuven, Belgium Not yet recruiting
Study contacts
- Principal investigator: Tine Van Damme, Prof. dr. — KU Leuven
- Study coordinator: Esther Meers
- Email: esther.meers@kuleuven.be
- Phone: +32 479976950
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AdiaVita and glutathione for autism in kids and teens
This study tests whether adding AdiaVita (cord-blood stem cells and exosomes) to glutathione helps improve ASD symptoms in children and other participants compared with glutathione alone.
-
Online test of BlinkLab Dx1 for autism in kids aged 2–11
This study tests whether the BlinkLab Dx1 smartphone app can help identify autism in children aged 2 to 11 by comparing app-based measurements with prior clinical diagnoses.
-
Trauma‑Focused Cognitive Behavioral Therapy adapted for autistic children and teens (pilot implementation)
This pilot will try TF‑CBT adapted for autistic children and teens with trauma-related symptoms to see if community mental health clinicians can deliver it and families find it acceptable.
-
CRUSH curriculum for romance and sexual health for autistic young adults
This project will try the CRUSH program—a group course plus one-to-one coaching—to teach sexual health and dating skills to autistic adults ages 18 to 30.
-
Static balance testing in children with autism using a virtual reality system
This project tests whether a virtual reality rehabilitation system can measure static balance differences in children with autism aged 6–10.
-
Do AdiaVita stem cells plus glutathione help kids with autism more than glutathione alone?
This 12-month study tests whether adding AdiaVita stem cells and exosomes to glutathione helps children aged 3–12 with autism more than glutathione alone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.